Ocular findings in allogeneic stem cell transplantation without total body irradiation

Ophthalmology

Volumn 106, Issue 7, 1999, Pages 1334-1338

  Kerty, Emília ^a,b   Vigander, Kaare ^a   Flage, Tor ^a   Brinch, Lorentz ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; THYMOCYTE ANTIBODY;

ADULT; ALLOGRAFT; ARTICLE; CATARACT; CONJUNCTIVITIS; EYE DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; KERATITIS; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; PAPILLEDEMA; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINOPATHY; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; UVEITIS; WHOLE BODY RADIATION;

EID: 0033513007     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)00720-4     Document Type: Article

References (32)

1. Armitage JO. Bone marrow transplantation [review]. N Engl J Med 1994;330:827-38.
2. Storb R, Donall Thomas E. The scientific foundation of marrow transplantation based on animal studies. In: Forman SJ, Blume KG, Donnall Thomas E, eds. Bone marrow transplantation. Boston: Blackwell Scientific Publications, 1994:3-11.
3. Sullivan KM. Graft-versus-host disease. In: Storb R, Donall Thomas E, eds. Bone marrow transplantation. Boston: Blackwell Scientific Publications, 1994:339-62.
4. Shulman HM, Sale GE, Lerner KG, et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978;92:545-70.
5. Sullivan KM, Shulman H M, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981;57:267-76.
6. Jack MK, Jack GM, Sale GE, et al. Ocular manifestations of graft-v-host disease. Arch Ophthalmol 1983;101:1080-4.
7. Jabs DA, Wingard J, Green WR, et al. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989;107:1343-8.
8. Coskuncan NM, Jabs DA, Dunn JP, et al. The eye in bone marrow transplantation: VI. Retinal complications. Arch Ophthalmol 1994;112:372-9.
9. Calissendorff BM, Lönnqvist B, el Azazi M. Cataract development in adult bone marrow transplant recipients. Acta Ophthalmol Scand 1995;73:152-4.
10. Deeg HJ, Flournoy N, Sullivan KM, et al. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 1984;10: 957-64.
11. Bjerrum KB. Keratoconjunctivitis sicca and primary Sjögren's syndrome in a Danish population aged 30-60 years. Acta Ophthalmol Scand 1997;75:281-6.
12. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987;70:1382-8.
13. Storb R, Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994;84:941-9.
14. Bernauer W, Gratwohl A, Keller A, Daicker B. Microvasculopathy in the ocular fundus after bone marrow transplantation. Ann Intern Med 1991;115:925-30.
15. Lopez PF, Sternberg P Jr, Dabbs CK, et al. Bone marrow transplant retinopathy. Am J Ophthalmol 1991;112:635-46.
16. Mencucci R, Rossi Ferrini C, Bosi A, et al. Ophthalmological aspects in allogenic bone marrow transplantation: Sjögren-like syndrome in graft-versus-host disease. Eur J Ophthalmol 1997;7:13-18.
17. Dunn JP, Jabs DA, Wingard J, et al. Bone marrow transplantation and cataract development. Arch Ophthalmol 1993;111: 1367-73.
18. Benyunes MC, Sullivan KM, Deeg HJ, et al. Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 1995;32:661-70.
19. Hirst LW, Jabs DA, Tutschka PJ, et al. The eye in bone marrow transplantation: I. Clinical study. Arch Ophthalmol 1983;101:580-4.
20. Jabs D A, Hirst LW, Green W R, et al. The eye in bone marrow transplantation: II. Histopathology. Arch Ophthalmol 1983;101:585-90.
21. Avery R, Jabs DA, Wingard JR, et al. Optic disc edema after bone marrow transplantation: possible role of cyclosporine toxicity. Ophthalmology 1991;98:1294-301.
22. Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393-401.
23. Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989;73:2018-24.
24. Katz B. Disk edema subsequent to renal transplantation. Surv Ophthalmol 1997;41:315-20.
25. Velu T, Debusscher L, Stryckmans P A. Cyclosporin-associated fatal convulsions [letter]. Lancet 1985;1(8422):219.
26. Jäger HR, Williams EJ, Savage DG, et al. Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia. AJNR Am J Neuroradiol 1996;17:1275-82.
27. Cruz OA, Fogg SG, Roper-Hall G. Pseudotumor cerebri associated with cyclosporine use. Am J Ophthalmol 1996;122: 436-7.
28. Ng P, McCluskey P, McCaughan G, et al. Ocular complications of heart, lung, and liver transplantation. Br J Ophthalmol 1998;82:423-8.
29. Franklin RM, Kenyon KR, Tutschka PJ, et al. Ocular manifestations of graft-vs-host disease. Ophthalmology 1983;90: 4-13.
30. Rouah E, Gruber R, Shearer W, et al. Graft-versus-host disease in the central nervous system. A real entity? Am J Clin Pathol 1988;89:543-6.
31. Hickey WF, Kimura H. Graft-vs-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci USA 1987;84:2082-6.
32. Flage T. The distribution of intravenously administered peroxidase in the optic nerve head of rabbit and monkey. Acta Ophthalmol (Copenh) 1975;53:801-8.